The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
5 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $12,061,951 in first-year total cost, median $1,212,634.
Most frequent study sections
- Special Emphasis Panel[ZCA1 SRB-A (M2)]3
- Special Emphasis Panel[ZCA1 RPRB-H (M2)]2
Most frequent institutions
- FRED HUTCHINSON CANCER CENTER2
- CLEVELAND CLINIC LERNER COM-CWRU1
- OREGON HEALTH & SCIENCE UNIVERSITY1
- UNIVERSITY OF CALIFORNIA LOS ANGELES1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | Strategically Engineered Multi-Antigen KSHV Vaccine: Integrating Humoral and Cellular Immunity for Effective Protection1U01CA305709-01 | PARDI, NORBERTWU, TING-TING | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $4,857,475 | ZCA1 |
| 2025 | Comprehensive Characterization of the T-cell Response to KSHV to Enable Specific Immune Therapy1U01CA295053-01A1 | WARREN, EDUS HOUSTON | FRED HUTCHINSON CANCER CENTER, WA | $4,234,248 | ZCA1 |
| 2024 | Targeting CD180 to induce anti-KSHV response in nonhuman primates1U01CA295049-01 | WONG, SCOTT W | OREGON HEALTH & SCIENCE UNIVERSITY, OR | $1,212,634 | ZCA1 |
| 2024 | Development of three KSHV vaccine platforms and chimeric MHV68-K-G for in vivo mouse infection study1U01CA294881-01 | JUNG, JAE U | CLEVELAND CLINIC LERNER COM-CWRU, OH | $989,903 | ZCA1 |
| 2024 | Defining Critical Sites of Vulnerability and Correlates of Protection to Kaposi Sarcoma Associated Herpesvirus to Inform Vaccine Design1U01CA295050-01 | BOONYARATANAKORNKIT, JIMMCGUIRE, ANDREWPHIPPS, WARREN | FRED HUTCHINSON CANCER CENTER, WA | $767,691 | ZCA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-11-0.1.2. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.